Experts tie chemotherapy to slight increase in AML risk

02/14/2013 | HealthDay News

Patients who underwent chemotherapy for non-Hodgkin lymphoma and esophageal, prostate and cervical cancers had an increased risk of developing acute myeloid leukemia, a study found. However, chemotherapy was associated with lower AML risk in ovarian cancer and myeloma, researchers said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI